Identification of advanced glycation end products of the Maillard reaction in Pick's disease

Neuroscience Letters

Volumn 219, Issue 2, 1996, Pages 95-98

  Kimura, Takemi ^a   Ikeda, Kazuyoshi ^a   Takamatsu, Junichi ^b   Miyata, Toshio ^c   Sobue, Gen ^c   Miyakawa, Taihei ^a   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Kikuchi National Hospital Division of Clinical Research   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Alzheimer's disease; Ballooned neurons; N( ) (Carboxymethyl)lysine; Pentosidinee; Pick's bodies; Pick's disease

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

AGED; ARGININE; BRAIN; DEMENTIA; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LYSINE; MAILLARD REACTION;

EID: 0030598374     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13173-6     Document Type: Article

References (22)

1. ∈-(carboxymethyl) lysine as a degradation product of fructoselysine in glycated protein, J. Biol. Chem., 261 (1986) 4889-4894.
2. [2] Bunn, H.F., Gabbay, K.H. and Gallop, P.M., The glycosylation of hemoglobin: relevance to diabetes mellitus, Science, 200 (1978) 21-27.
3. ∈-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions, J. Biol. Chem., 271 (1996) 9982-9986.
4. [4] Hill, W.D., Lee, V.M.-Y., Hurtig, H.I., Murray, J.M. and Trojanowski, J.Q., Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies, J. Comp. Neurol., 309 (1991) 150-160.
5. [5] Horiuchi, S., Araki, N. and Morino, Y., Advanced glycation end products of the Maillard reaction: evidence for the presence of a common structure, J. Biol. Chem., 266 (1991) 7329-7332.
6. ∈-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction, Biochemistry, 35 (1996) 8075-8083.
7. [7] Kimura, T., Takamatsu, J., Araki, N., Goto, M., Kondo, A., Miyakawa, T. and Horiuchi, S., Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?, NeuroReport, 6 (1995) 866-868.
8. [8] Kimura, T. and Horiuchi, S., Amyloidosis, advanced glycation end products and Alzheimer's disease: reply, NeuroReport, 6 (1995) 1595-1596.
9. [9] Kimura, T., Takamatsu, J., Ikeda, K., Kondo, A., Miyakawa, T. and Horiuchi, S., Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons, Neurosci. Lett., 208 (1996) 53-56.
10. [10] Kume, S., Takeya, M., Mori, T., Araki, N., Suzuki, H., Horiuchi, S., Kodama, T., Miyauchi, Y. and Takahashi, K., Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta using a novel specific monoclonal antibody, Am. J. Pathol., 147 (1995) 654-667.
11. [11] Love, S., Saitoh, T., Quijada, S., Cole, G.M. and Terr, R.D., Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies, J. Neuropathol. Exp. Neurol., 47 (1988) 393-405.
12. [12] Maillard, L.C., Action des acides amines sur les sucres: formation des melanoidines par voie methodique, C.R. Acad. Sci. (Paris), 154 (1912) 66-68.
13. [13] Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A. and Vlassara, H., Advanced glycosylation end products in patients with diabetic nephropathy, N. Engl. J. Med., 325 (1991) 836-842.
14. [14] Mattson, M.P., Carney, J.W. and Butterfield, D.A., A tombstone in Alzheimer's?, Nature, 373 (1995) 481.
15. [15] Monnier, V.M., Nonenzymatic glycosylation, the Maillard reaction and the aging process, J. Gerontol., 45 (1990) B105-111.
16. [16] Nakamura, K., Hasegawa, T., Fukunaga, Y. and Ienaga, K., Crosslines A and B as candidates for the fluorophores in age-and diabetes-related cross-linked proteins, and the diacetates produced by Maillard reaction of α-N-acetyl-L-lysine with D-glucose, J. Chem. Soc. Chem. Commun., 14 (1992) 992-994.
17. [17] Ono, T., Yamamoto, H., Tashima, K., Nakashima, H., Okumura, E., Yamada, K., Hisanaga, S., Kishimoto, T., Miyakawa, T. and Miyamoto, E., Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease, Neurochem. Int., 26 (1995) 205-215.
18. [18] Sell, D.R. and Monnier, V.M., End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen, J. Clin. Invest., 85 (1990) 380-384.
19. [19] Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Yan, S.-D., Stern, D., Sayre, L.M., Monnier, V.M. and Perry, G., Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. USA, 91 (1994) 5710-5714.
20. [20] Taneda, S. and Monnier, V.M., ELISA of pentosidine, an advanced glycation end product, in biological specimens, Clin. Chem., 40 (1994) 1766-1773.
21. [21] Ulrich, J., Haugh, M., Anderton, B.H., Probst, A., Lautenschlager, C. and His, B., Alzheimer dementia and Pick's disease: neurofibrillary tangles and Pick bodies are associated with identical phosphorylated neurofilament epitopes, Acta Neuropathol. (Berlin), 73 (1987) 240-246.
22. [22] Yasuhara, O., Matsuo, A., Tooyama, I., Kimura, H., McGeer, E.G. and McGeer, P.L., Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons, Acta Neuropathol., 89 (1995) 322-330.